Pakistan Urged By MNC Drug Maker To Allow Higher Drug Prices
This article was originally published in PharmAsia News
Executive Summary
The Pakistan government is being urged by GlaxoSmithKline Pakistan to deregulate the prices of legitimate drugs sold in the country